436 Success of Debridement, Antibiotics, and Implant Retention vs. Revision in Early and Late Prosthetic Joint Infections following Primary Total Knee Arthroplasty: A Prospective, Multicenter Study of 251 Cases

437 Does the Timing of Antibiotic Administration Affect Culture Results in Resection Arthroplasty for Periprosthetic Joint Infection?

438 Associations Between Wound Closure Method and Outcomes in the Treatment of Prosthetic Joint Infection

439 Activity of the Novel Engineered Antimicrobial Peptide PLG0206 against Staphylococci and Enterococci that Cause Periprosthetic Joint Infections

440 Antiseptic Solutions in Knee Arthroplasty: Does Efficacy against Biofilm Change on Different Surfaces?